Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Inflammatory Bowel Diseases

  Free Subscription


2 Aliment Pharmacol Ther
2 BMC Gastroenterol
6 Dig Dis Sci
3 Eur J Gastroenterol Hepatol
2 Gastroenterology
1 Inflamm Bowel Dis
1 J Clin Gastroenterol
2 J Crohns Colitis
2 Lancet Gastroenterol Hepatol
1 Mediators Inflamm
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Aliment Pharmacol Ther

  1. ARATARI A, Scribano ML, Pugliese D, Baccolini V, et al
    Crohn's disease after surgery: Changes in post-operative management strategies over time and their impact on long-term re-operation rate-A retrospective multicentre real-world study.
    Aliment Pharmacol Ther. 2024 Apr 14. doi: 10.1111/apt.18001.
    PubMed         Abstract available

  2. KIM K, Park JJ, Yoon H, Lee J, et al
    Application of clinical decision support tools for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: A KASID multicentre study.
    Aliment Pharmacol Ther. 2024 Apr 14. doi: 10.1111/apt.17989.
    PubMed         Abstract available

    BMC Gastroenterol

  3. MENESY A, Hammad M, Aref S, Abozeid FAM, et al
    Level of interleukin 17 in inflammatory bowel disease and its relation with disease activity.
    BMC Gastroenterol. 2024;24:135.
    PubMed         Abstract available

  4. NOROUZKHANI N, Faramarzi M, Bahari A, Shirvani JS, et al
    Inflammatory bowel disease patients' perspectives of non-medical needs.
    BMC Gastroenterol. 2024;24:134.
    PubMed         Abstract available

    Dig Dis Sci

  5. LAMICHHANE N, Melas N, Bergqvist V, Ekholm NP, et al
    Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Apr 18. doi: 10.1007/s10620-024-08422.
    PubMed         Abstract available

  6. KANE K, Velayos FS, Lee JK, Cherny S, et al
    A Response-able Diagnosis: Type 2 Autoimmune Pancreatitis in the Setting of Ulcerative Colitis.
    Dig Dis Sci. 2024 Apr 18. doi: 10.1007/s10620-024-08408.

  7. DJALAL A, Wong SY, Colombel JF, Ungaro R, et al
    Problem with Hookups: Perianal Fistula After Ileal Pouch-Anal Anastomosis.
    Dig Dis Sci. 2024;69:1102-1104.

  8. CLINTON J, Motwani KK, Schwartz S, McCarthy P, et al
    Upadacitinib as Rescue Therapy for the Treatment of Acute Severe Colitis in an Acute Care Setting.
    Dig Dis Sci. 2024;69:1105-1109.
    PubMed         Abstract available

  9. SINGH A, Mahajan R, Midha V, Kaur K, et al
    Effectiveness of Tofacitinib in Ulcerative Proctitis Compared to Left Sided Colitis and Pancolitis.
    Dig Dis Sci. 2024;69:1389-1402.
    PubMed         Abstract available

  10. HUSSAIN N, Trivedi PJ
    Risk Stratification in Primary Sclerosing Cholangitis: Does Size Matter?
    Dig Dis Sci. 2024 Feb 12. doi: 10.1007/s10620-023-08262.

    Eur J Gastroenterol Hepatol

  11. SUN Z, Cao L, Chen Y, Zhu W, et al
    Long-term outcomes of intestinal penetrating Crohn's disease following successful nonoperative management.
    Eur J Gastroenterol Hepatol. 2024 Apr 5. doi: 10.1097/MEG.0000000000002775.
    PubMed         Abstract available

  12. TEPES K, Hanzel J, Stubljar D, Strmsek K, et al
    Biological treatment approach to inflammatory bowel disease is similar in academic and nonacademic centres - prime time for decentralisation of inflammatory bowel disease care?
    Eur J Gastroenterol Hepatol. 2024 Apr 2. doi: 10.1097/MEG.0000000000002771.
    PubMed         Abstract available

  13. WESTON F, Carter B, Powell N, Young AH, et al
    Antidepressant treatment in inflammatory bowel disease: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2024 Apr 5. doi: 10.1097/MEG.0000000000002768.
    PubMed         Abstract available


  14. KEEFER L, Hashash JG, Szigethy E, Mayer EA, et al
    AGA Clinical Practice Update on Pain Management in Inflammatory Bowel Disease: Commentary.
    Gastroenterology. 2024 Apr 17:S0016-5085(24)00358.
    PubMed         Abstract available

  15. ZOLLNER A, Koch R, Jukic A, Pfister A, et al
    Clearance of gut mucosal SARS-CoV-2 antigens and post-acute COVID-19 after two years in patients with inflammatory bowel disease.
    Gastroenterology. 2024 Apr 15:S0016-5085(24)00423.

    Inflamm Bowel Dis

  16. AL RADI ZMA, Prins FM, Collij V, Vich Vila A, et al
    Exploring the Predictive Value of Gut Microbiome Signatures for Therapy Intensification in Patients With Inflammatory Bowel Disease: A 10-Year Follow-up Study.
    Inflamm Bowel Dis. 2024 Apr 18:izae064. doi: 10.1093.
    PubMed         Abstract available

    J Clin Gastroenterol

  17. KARIME C, Salazar M, Black CN, Caldera F, et al
    In Patients With Inflammatory Bowel Disease, Racial Disparities Exist in Burden of Vaccine-preventable Disease Hospitalizations and Outcomes.
    J Clin Gastroenterol. 2024 Apr 16. doi: 10.1097/MCG.0000000000002005.
    PubMed         Abstract available

    J Crohns Colitis

  18. BURTON-MURRAY H, Kiser K, Gurung J, Williams K, et al
    Avoidant/restrictive food intake disorder symptoms are not as frequent as other eating disorder symptoms when ulcerative colitis is in remission.
    J Crohns Colitis. 2024 Apr 18:jjae052. doi: 10.1093.
    PubMed         Abstract available

  19. BROWN M, Dodd A, Shi F, Greenwood E, et al
    Concordant B and T Cell Heterogeneity Inferred from the Multiomic Landscape of Peripheral Blood Mononuclear Cells in a Crohn's Disease Cohort.
    J Crohns Colitis. 2024 Apr 13:jjae055. doi: 10.1093.
    PubMed         Abstract available

    Lancet Gastroenterol Hepatol

  20. PARKES GC, Hedin CRH
    PANTS extension study: how best to use anti-TNF drugs in Crohn's disease.
    Lancet Gastroenterol Hepatol. 2024 Apr 16:S2468-1253(24)00088.

  21. CHANCHLANI N, Lin S, Bewshea C, Hamilton B, et al
    Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study.
    Lancet Gastroenterol Hepatol. 2024 Apr 16:S2468-1253(24)00044.
    PubMed         Abstract available

    Mediators Inflamm

  22. HONG S, Wang H, Chan S, Zhang J, et al
    Identifying Macrophage-Related Genes in Ulcerative Colitis Using Weighted Coexpression Network Analysis and Machine Learning.
    Mediators Inflamm. 2023;2023:4373840.
    PubMed         Abstract available

    PLoS One

  23. WU H, Jiang F, Yuan W, Zhao Y, et al
    Rauwolfia polysaccharide can inhibit the progress of ulcerative colitis through NOS2-mediated JAK2/STAT3 pathway.
    PLoS One. 2024;19:e0301660.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.